Literature DB >> 3726799

Pulmonary vascular effects of a fibrin(ogen)-derived vasoactive peptide.

D F Kern, K Saldeen, T Saldeen, A B Malik.   

Abstract

We examined the effects of the 5 amino acid fibrin(ogen)-degradation product Ala-Arg-Pro-Ala-Lys (Peptide 6A) on pulmonary hemodynamics and vascular permeability in the isolated-perfused guinea pig lung. Infusion of this peptide (100 mumoles) resulted in a small increase in pulmonary vascular resistance. The pulmonary vasoconstrictor responses was not mediated by histamine or cyclooxygenase metabolites since neither H1 blockers nor meclofenamate inhibited the response. The capillary filtration coefficient (a measure of water transvascular permeability) did not change after Peptide 6A infusion. Small molecular weight fibrin(ogen)-degradation products may contribute to increased pulmonary vascular resistance associated with pulmonary intravascular coagulation, but not to the increase in lung hydraulic conductivity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3726799     DOI: 10.1016/0049-3848(86)90114-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness.

Authors:  Scott S Wagers; Ryan J Norton; Lisa M Rinaldi; Jason H T Bates; Burton E Sobel; Charles G Irvin
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

Review 2.  Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease.

Authors:  D Lominadze; W L Dean; S C Tyagi; A M Roberts
Journal:  Acta Physiol (Oxf)       Date:  2009-09-01       Impact factor: 6.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.